These observations, together with our earlier study and the lack of specificity to some other defined breast cancer antigens, including HER-2/neu [23], suggest that efficient cross-presentation of individual tumor antigens by DCs loaded with killed breast cancer cells will depend on the nature of these antigens or the form in which they are taken up by DCs. Here, ERBB2 is linked to neoplasm.